Skip to the answer

Rifaximin Uses, Dosage, Side Effects and Interactions

Brand name
Xifaxan

Xifaxan was the first rifaximin product the FDA approved, in May 2004. No generic is listed as tablets.

First generic of Xifaxan: our estimate, January 2028

Rifaximin is an antibiotic that works mainly in the gut and is used to treat travelers’ diarrhea, lower the risk of hepatic encephalopathy coming back, and treat irritable bowel syndrome with diarrhea (IBS-D).

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 19, 2026 Where our facts come from

Quick links

Ask Anything About RifaximinType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Rifaximin in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Rifaximin (Xifaxan), on the U.S. market since about 2004, is an antibiotic that acts mainly in the gut. It is used to treat travelers’ diarrhea caused by E. coli and IBS-D (irritable bowel syndrome with diarrhea), and to lower the chance of hepatic encephalopathy (confusion from liver disease) coming back, usually as an add-on to lactulose. Since little of it is absorbed, most people tolerate it well, and nausea or headache are what people notice most. Watch for diarrhea that worsens, brings fever or blood, or starts even weeks after treatment, since that can signal C. difficile, a serious gut infection.

Key Takeaways From the HelloPharmacist Team

  • Take it with or without food, three times a day for travelers’ diarrhea or IBS-D, and twice a day for hepatic encephalopathy.
  • Travelers’ diarrhea needs only a 3-day course, but call your prescriber if it worsens or lasts beyond 24 to 48 hours.
  • For hepatic encephalopathy, keep taking it every day even when your thinking feels clear, because its job is preventing the next episode.
  • If you take warfarin, expect extra INR blood checks after starting, because rifaximin can shift your INR.

How we write and review this content: our editorial policy

Rifaximin by the Numbers

Strengths
2
in one form
Makers and packagers
3
Earliest FDA record
2004
Rank by Medicaid prescriptions
#493 of 1,682 drugs
More prescriptions than 70% of the 1,682 drugs we measure
118,294 prescriptions, Q1–Q4 2025

Patient Information Guide for Rifaximin

What It’s Used For

Rifaximin is an antibiotic used for gut-related and liver-related conditions. Xifaxan tablets, taken by mouth, are approved for:

  • Travelers’ diarrhea caused by noninvasive E. coli in adults and children 12 and older
  • Reducing the risk of overt hepatic encephalopathy recurrence in adults
  • Irritable bowel syndrome with diarrhea (IBS-D) in adults

How It Works

Rifaximin is a rifamycin antibacterial drug. Only a small amount is absorbed in most people, and nearly all of it leaves the body in the stool. That is why it works mainly inside the gut and is not suitable for infections that spread through the body.

Drug Class

Drug Class

  • Rifamycin Antibacterial
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • Rifamycin Antibacterial

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)

None listed for Rifaximin in the FDA’s index.

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)

None listed for Rifaximin in the FDA’s index.

From our Patient Information GuideRifaximin is a rifamycin antibacterial drug. Only a small amount is absorbed in most people, and nearly all of it leaves the body in the stool. Read How Rifaximin Works

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)
  • Rifamycins

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Antibiotics
  • Other antibiotics for topical use

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

Xifaxan tablets are swallowed by mouth, with or without food. The schedule depends on the condition.

  • Travelers’ diarrhea: three times daily for 3 days
  • Hepatic encephalopathy: twice daily
  • IBS-D: three times daily for 14 days, with up to two repeat courses if symptoms return

Follow your prescriber’s directions and your pharmacy label.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Travelers' diarrhea

For adults and children 12 years old and older
Usual dose 200 mg 3 times a day for 3 days

Lowering the risk of confusion from liver disease coming back (hepatic encephalopathy)

For adults
Usual dose 550 mg 2 times a day

Irritable bowel syndrome with diarrhea

For adults
Usual dose 550 mg 3 times a day for 14 days
  • Patients who experience recurrence can be retreated up to 2 times with the same regimen

Good to Know for Every Dose

Can be taken with or without food

See the Full Dosing Instructions on DailyMed →

Side Effects

Side effects vary by condition. Commonly reported ones include:

Common side effects

  • Headache (travelers’ diarrhea)
  • Nausea
  • Swelling in the legs or ankles (peripheral edema)
  • Dizziness
  • Tiredness
  • Constipation
  • Raised liver test (ALT) results (IBS-D)
  • Belly fluid buildup (ascites)
  • Swelling in the legs, dizziness, tiredness, constipation, itching, anemia, and belly fluid (hepatic encephalopathy)

When to get medical help

  • Call your doctor if diarrhea gets worse or lasts more than 24 to 48 hours while treating travelers’ diarrhea, or if you have a fever or blood in the stool.
  • Tell your doctor if you have new or worsening diarrhea during or even weeks after antibiotic treatment. It could be C. difficile infection, which can be severe.
  • Get urgent help for signs of an allergic reaction, such as swelling of the face or tongue, trouble swallowing, hives, flushing, or a widespread rash. These can start within 15 minutes of a dose.
  • Stop the medicine and call your doctor at the first sign of a severe skin reaction, such as peeling or blistering skin. These have been reported in people with cirrhosis.
  • Report unexplained muscle pain or weakness, especially if you have cirrhosis. Rhabdomyolysis (serious muscle breakdown) has been reported.

Warnings and Precautions

  • C. difficile diarrhea: It can occur with nearly any antibiotic, even more than two months after treatment, and can be serious.
  • Travelers’ diarrhea: It is not effective if you have fever or bloody stool, or if the cause is not E. coli. Stop and call your doctor if symptoms worsen or last more than 24 to 48 hours.
  • Resistance: Using it without a proven or strongly suspected bacterial infection is unlikely to help and may promote drug-resistant bacteria.
  • Severe liver disease: Exposure is much higher, so caution is advised.
  • Allergy and skin reactions: Serious allergic and severe skin reactions have been reported.

Interactions

A few medicines can change how rifaximin or other drugs behave.

  • Cyclosporine and other P-glycoprotein inhibitors: they can substantially raise rifaximin levels, especially in people with liver impairment.
  • Warfarin: INR changes have been reported, so monitoring is needed and the warfarin dose may need adjusting.

Interactions Listed in the FDA-Approved Label

From the Rifaximin prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • What happensChanges in INR have been reported postmarketing in patients receiving rifaximin and warfarin together.
    What to doMonitor INR and prothrombin time; dose adjustment of warfarin may be needed to maintain target INR range.
  • P-glycoprotein inhibitors such as cyclosporine
    What happensCyclosporine, an inhibitor of P-gp and OATPs, significantly increased the systemic exposure of rifaximin; in hepatic impairment the increase may be further.
    What to doCaution should be exercised when concomitant use of XIFAXAN and a P-gp inhibitor such as cyclosporine is needed.
  • CYP3A4 substrates
    What happensAn in vitro study suggested rifaximin induces CYP3A4, but in patients with normal liver function XIFAXAN at the recommended regimen is not expected to induce CYP3A4; the effect in patients with reduced liver function is unknown.
Read the label’s full interactions text

7 DRUG INTERACTIONS Warfarin: Monitor INR and prothrombin time; dose adjustment of warfarin may be needed to maintain target INR range. 7.1 P-glycoprotein Inhibitors Concomitant administration of cyclosporine, an inhibitor of P-gp and OATPs significantly increased the systemic exposure of rifaximin. In patients with hepatic impairment, a potential additive effect of reduced metabolism and concomitant P-gp inhibitors may further increase the systemic exposure to rifaximin. Caution should be exercised when concomitant use of XIFAXAN and a P-gp inhibitor such as cyclosporine is needed. 7.2 Warfarin Changes in INR have been reported postmarketing in patients receiving rifaximin and warfarin concomitantly. Monitor INR and prothrombin time. Dose adjustment of warfarin may be needed to maintain target INR range. See prescribing information for warfarin. 7.3 CYP3A4 Substrates An in vitro study has suggested that rifaximin induces CYP3A4. However, in patients with normal liver function, XIFAXAN at the recommended dosing regimen is not expected to induce CYP3A4. It is unknown whether rifaximin can have a significant effect on the pharmacokinetics of concomitant CYP3A4 substrates in patients with reduced liver function who have elevated rifaximin concentrations.

Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Do not use if you are allergic to rifaximin, other rifamycin antibiotics, or any tablet ingredient.
  • Use caution with severe (Child-Pugh Class C) liver disease.
  • Pregnancy: animal studies showed harm to the fetus, and there are no human data.
  • Breastfeeding: it is not known whether it passes into breast milk, so discuss with your doctor.
  • Children: not established under 12 for travelers’ diarrhea, or under 18 for hepatic encephalopathy and IBS-D.
  • Older adults: no overall differences were seen in the hepatic encephalopathy and IBS-D studies, but some may be more sensitive.
  • Kidney disease: it has not been studied in people with impaired kidney function.

Overdose

No specific treatment for overdose is available. In studies, higher-than-recommended doses caused side effects similar to placebo. If too much is taken, the medicine should be stopped and symptoms treated with supportive care.

Half-Life and How Your Body Processes It

Very little rifaximin enters the bloodstream in people with normal liver function. It peaks in about an hour, and its half-life is roughly 6 hours at steady state. Most of it leaves in the stool, largely unchanged. The part that is absorbed is mainly broken down by the CYP3A4 enzyme. People with liver impairment have much higher blood levels. A high-fat meal raises exposure about 2-fold, but the tablets can be taken with or without food.

Storage

Store XIFAXAN Tablets at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) .

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Supplements and Herbs That Interact With Rifaximin

From the licensed clinical database we use, rolled up per supplement, most serious first.

44 supplements and herbal products have documented interactions with Rifaximin in the licensed clinical database we use.

Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.

  • 1Major
  • 33Moderate
  • 10Minor

See the other 36

Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

Nutrients Rifaximin May Deplete

Nutrients Rifaximin has been linked with lower levels of, from the licensed clinical database we use.

Rifaximin has been associated with lower levels of 7 nutrients in the clinical literature. This does not mean a deficiency will occur. It means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.

Evidence and significance: 1 moderate, 6 lower / possible

Educational information from a licensed clinical database (Natural Medicines), not medical advice. Do not start or stop medications or supplements without professional guidance.

Rifaximin: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Rifaximin — the kind of thing our pharmacy team would talk through with you at the counter.

What is rifaximin used for?

Xifaxan tablets treat travelers’ diarrhea caused by noninvasive E. coli. They also lower the chance that hepatic encephalopathy, a liver-related confusion, comes back, and they treat IBS-D in adults. Which use applies to you depends on why your prescriber chose it.

Can I take rifaximin with food?

Yes. Xifaxan can be taken with or without food, so take it in whatever way is easiest for you to remember.

What side effects should I expect?

Headache and nausea are among the more common ones. If you take it for hepatic encephalopathy, swelling, dizziness, tiredness, and constipation can also occur. Call your doctor if you get severe or lasting diarrhea, a rash, swelling of the face or tongue, or peeling skin.

Should I keep taking it if my travelers’ diarrhea isn’t getting better?

If your diarrhea gets worse or lasts more than 24 to 48 hours, or you develop a fever or blood in your stool, call your doctor. Rifaximin may not be the right antibiotic for that kind of infection, and your doctor may switch you.

Does rifaximin interact with other medicines?

Yes, in a couple of ways. Cyclosporine can raise rifaximin levels, and rifaximin can change INR results if you take warfarin. Tell me about all your medicines so we can check, and your doctor may monitor your INR.

Is rifaximin safe during pregnancy?

There are no human data, and animal studies showed birth defects. If you are pregnant or planning to be, talk with your doctor before taking it.

Is rifaximin available over the counter?

No. Rifaximin is a prescription medicine: every rifaximin product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was rifaximin first available?

The earliest FDA record we hold for rifaximin is from 2004: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when rifaximin was first used.

Who makes rifaximin?

3 companies currently list rifaximin products in the FDA's NDC Directory, including Salix Pharmaceuticals, Inc., A-S Medication Solutions, Cardinal Health 107, LLC. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

What is the brand name of rifaximin?

Rifaximin is the generic name. Its brand name is Xifaxan.

What is the generic name of Xifaxan?

The generic name of Xifaxan is rifaximin. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is rifaximin?

Rifaximin belongs to the drug class Rifamycin Antibacterial, its established pharmacologic class on the FDA label.

What strengths does rifaximin come in?

Rifaximin is listed in the FDA's National Drug Code Directory in these forms and strengths. Tablet (by mouth): 200 mg and 550 mg. A listing does not mean every pharmacy stocks every strength.

How much does rifaximin cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, pharmacies paid a national average of $10.72 to $55.28 per tablet of brand-name Xifaxan across 2 strengths as of October 1, 2025 (CMS's NADAC survey). That is the pharmacy's own cost for the medicine, not the price at the counter. The pharmacy prices section of this page lists every strength priced.

Is there a rifaximin shortage?

No. Rifaximin is not on the FDA's drug shortage list as of Nov 21, 2026. A single pharmacy can still run short for a while without a national shortage, and your pharmacist can tell you what they are seeing.

Where can I read the rifaximin prescribing information (package insert)?

The full FDA-approved prescribing information for rifaximin, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Salix Pharmaceuticals, Inc.'s, revised Jun 25, 2025, and links to it on DailyMed.

Is rifaximin gluten free?

No rifaximin label we read lists an ingredient made from wheat, barley or rye, the grains that carry gluten, and none names a starch, dextrin or maltodextrin without saying where it comes from. We read the FDA labels of 4 rifaximin products from 3 companies. A label lists ingredients; it is not a gluten test, so we cannot promise that any product has no gluten. If you have celiac disease, ask the company for a written gluten statement. Our Inactive Ingredient Checker shows each company's rifaximin by strength and NDC, and whether its label lists a gluten source, lactose, dyes or any other inactive ingredient. See rifaximin inactive ingredients by company

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Rifaximin

Skip the scrolling. Ask in your own words and get an answer from Rifaximin’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Rifaximin’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Rifaximin on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Rifaximin Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Rifaximin Forms and Strengths (How It Comes)

Rifaximin comes in 1 dose form, the tablet. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Rifaximin inactive ingredients by manufacturer.

Tablet

By mouth
Brands Xifaxan (the first brand, 2004)
How this form is used
What it may be used for
  • Xifaxan is used for travelers’ diarrhea caused by noninvasive E. coli in people 12 and older.
  • Xifaxan is used to reduce the risk of overt hepatic encephalopathy coming back in adults.
  • Xifaxan is used to treat IBS-D in adults.
Important instructions
  • Xifaxan tablets are taken by mouth.
  • Xifaxan can be taken with or without food.
  • Xifaxan for IBS-D can be repeated up to two times if symptoms return, using the same regimen.
Available strengths 2 strengths
4 FDA-listed product records ⓘ

Rifaximin on the U.S. Market: Products, Makers and Brands

How Rifaximin appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

3 companies list 4 Rifaximin product records with the FDA, mostly as tablet; the earliest marketing or approval year on record is 2004. The one brand name in the directory today is Xifaxan; the rest are generics.

1
Dose forms ⓘ
3
Labelers (makers, repackagers, distributors)
1
Brand names ⓘ
4
FDA-listed product records ⓘ
2004
Earliest FDA record ⓘ

Also listed with the FDA, not a patient dose form: Powder (18) · Unfinished tablet (1) · Unfinished tablet, coated (1) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

Salix Pharmaceuticals, Inc.50%
A-S Medication Solutions25%
Cardinal Health 107, LLC25%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How Widely Rifaximin Is Used (Medicaid Data)

How many Rifaximin prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

118,294
Medicaid prescriptions filled (Q1–Q4 2025)
$339.4M paid by Medicaid, before rebates

How commonly is Rifaximin prescribed? Of the 1,682 medications we measure, Rifaximin ranks #493 by Medicaid prescriptions — more than 71% of them.

Where Rifaximin ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Rifaximin product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 550 mg oral tablet is the most-dispensed Rifaximin product — about 100% of these Medicaid prescriptions.

rifaximin 550 MG Oral Tablet Most dispensed

118,152 Medicaid prescriptions (Q1–Q4 2025) 100% of Rifaximin prescriptions shown $339.4M paid by Medicaid, before rebates ≈ $2,872 per prescription, before rebates

2 of 8 listed NDCs had Medicaid claims. RxNorm 856664

rifaximin 200 MG Oral Tablet

142 Medicaid prescriptions (Q1–Q4 2025) <1% of Rifaximin prescriptions shown $55,941 paid by Medicaid, before rebates ≈ $394 per prescription, before rebates

1 of 4 listed NDCs had Medicaid claims. RxNorm 429662

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 3 of the 12 listed Rifaximin NDCs had Medicaid claims.

Compare Rifaximin Products

A representative set of FDA-listed product records for Rifaximin — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Strength Route Manufacturer / Labeler Category ⓘ Details
💊Tablet
200 mg Oral A-S Medication Solutions NDA View NDC →
550 mg Oral Cardinal Health 107, LLC NDA View NDC →
200 mg Oral Salix Pharmaceuticals, Inc. NDA View NDC →
550 mg Oral Salix Pharmaceuticals, Inc. NDA View NDC →

Showing 4 of 4 products — FDA National Drug Code Directory. See every product, package size and price: browse all 4 Rifaximin NDCs →

Rifaximin Side Effects Reported to the FDA (FAERS)

After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Rifaximin — a signal of what to watch for, not proof the drug caused it.

The effects most often named in FDA reports that mention Rifaximin are death, hospitalisation, diarrhoea; about 78% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.

21,335
Reports mentioning it
78%
Reported as serious
12
Distinct effects shown
Most reported effects
Death
4,264
Hospitalisation
1,954
Diarrhoea
1,258
Therapy Interrupted
1,176
Ammonia Increased
862
Nausea
854
Hepatic Encephalopathy
836
Fatigue
815
Confusional State
733
Insurance Issue
729
Age groups
Adult · 1,719Elderly · 1,094Child · 30Adolescent · 23Infant · 6Neonate · 5

Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Rifaximin in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.

Rifaximin FDA Approval History

How Rifaximin went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.

Rifaximin was first approved by the FDA in 2004 (Brand: XIFAXAN · Salix Pharms); the first generic version was approved in 2026. It remains available in U.S. pharmacies today.

2004
Brand approved
Brand: XIFAXAN · Salix Pharms
2026
First generic approved
Lower-cost ANDA competition begins

Source: Drugs@FDA.

Rifaximin Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Rifaximin recalls since July 2021.

✅No Rifaximin recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Rifaximin in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
1
Strengths
2
Forms in current FDA listings
1 of 1
In current FDA listings No current FDA listing
Ingredient (IN) Rifaximin RxCUI 35619
  1. Dose form (SCDF) Oral Tablet RxCUI 451309
    In current FDA listings
    Its 2 strengths (SCD)

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Rifaximin Costs Pharmacies (NADAC Benchmark)

What pharmacies pay to buy Rifaximin: the national average from CMS’s weekly NADAC survey, as of Oct 1, 2025. It is the pharmacy’s cost, not your price at the counter.

How the Pharmacy Price Has Changed

Pick a strength to see how its price has changed since Sep 2023.

Strength

For brand-name Xifaxan, the 200 mg tablet, pharmacies paid an average of $10.72 per tablet as of Oct 1, 2025, up 6% from $10.11 a year earlier.

What pharmacies pay now
$10.72
per tablet, as of Oct 1, 2025
Last 4 weeks
No change
from $10.72 on Sep 3, 2025
Last 12 months
Up 6%
from $10.11 on Oct 2, 2024
Lowest and highest since Sep 2023
$9.78 to $10.72
per tablet

Each step is one weekly survey. Arrow keys on the chart move week by week.
See the numbers, month by month
Xifaxan 200 mg tablet: the average pharmacy price per tablet, the last survey of each month
MonthPharmacy price
Oct 2025$10.72
Sep 2025$10.72
Aug 2025$10.72
Jul 2025$10.72
Jun 2025$10.72
May 2025$10.72
Apr 2025$10.72
Mar 2025$10.72
Feb 2025$10.72
Jan 2025$10.72
Dec 2024$10.11
Nov 2024$10.11
Oct 2024$10.11
Sep 2024$10.11
Aug 2024$10.11
Jul 2024$10.11
Jun 2024$10.11
May 2024$10.11
Apr 2024$10.11
Mar 2024$10.11
Feb 2024$10.11
Jan 2024$10.11
Dec 2023$9.78
Nov 2023$9.78
Oct 2023$9.78
Sep 2023$9.78
FormStrengthVersion What pharmacies pay
Tablet · Oral 200 mg Xifaxan (brand) $10.72 per tablet NDC details & price history
Tablet · Oral 550 mg Xifaxan (brand) $55.28 per tablet NDC details & price history
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.

Rifaximin Brand Names

Rifaximin has one brand name on record: Xifaxan. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Xifaxan the first brand, 2004

Who Makes Rifaximin: Manufacturers and Labelers

3 companies list Rifaximin products with the FDA. By number of product records, the largest are Salix Pharmaceuticals, Inc., A-S Medication Solutions, Cardinal Health 107, LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Salix Pharmaceuticals, Inc. 2 A-S Medication Solutions 1 Cardinal Health 107, LLC 1

Sources for This Rifaximin Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Jun 25, 2025, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Rifaximin.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 3 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
3
Finished products in the current FDA directory
4
Companies listing them (makers, repackagers, distributors)
3
FDA labeler codes behind them ⓘ
3
Linked representative label ⓘ
Salix Pharmaceuticals, Inc.
Linked label effective
Jun 25, 2025
Composite sections available
20
Linked SPL Set ID
c5e8e2fd-7087-4b78-9181-cc259c0be2f1
Linked SPL Document ID
b2e9bb84-e97e-4e7e-8a23-425418b4374d
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Salix Pharmaceuticals, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →